The rapid progression of technology leading into today's post-genomic era has created both problem and opportunity. The success of genomic research, particularly the structural genomic component, has spawned a rash of new '-omics' -- proteomics, metabolomics, immunomics, transcriptomics and others. The tools enabling these new efforts to reveal the larger biological picture are rapidly emerging. While physical machinery is required, the biggest challenges are being addressed by informatics, computer applications addressing the data storage, manipulation and analysis needs.

As became apparent in the race to map the human genome, traditional approaches often prove unsuitable to new challenges. While brute force and large-scale automation were suitable for DNA sequencing, the proteome now poses a much tougher challenge. Proteomics' larger 'alphabet' comprised of 22 amino acid building blocks and numerous intricate folding patterns determines the specific protein generated. 'Smarter' approaches dictate teamwork drawing upon an assortment of specialized skills.

The future of drug target discovery, diagnostics, therapeutics, and individualized medicine will spring from today's emerging technologies. The life sciences industry driving this development encompasses pharmaceutical, genomic research, and biotechnology companies, academic institutions, and government laboratories.

We at Third Nerve believe that no single organization is capable of efficiently and timely addressing the research challenges before us. This assertion has led us to develop our novel bio-discovery platform and methodology. Our techniques and practices afford a better environment for successful discovery while increasing the likelihood of commercially viable research output. We provide a balance of incentive and and risk adaptation strategies ensuring adequate and equitable compensation for all participants.

Our dynamic collaboration model readily absorbs the most promising technologies into the entire Third Nerve research portfolio. Our dedication to uncovering and presenting the cutting-edge in math and science may well be the key to unlocking your research challenge. The multi-pronged nature of our approach is more economical and productivity-enhancing than static partnering or collaboration agreements.

We expect to bring forth a transformational increase in the speed of drug target, diagnostic, and therapeutic development.

Third Nerve...

creates optimal environments advancing life science; realizes greater potential in medical and biological discovery; brings top minds together to tackle our toughest research questions; and organizes science, finance, and marketing with proper perspective and direction.

Choose to do your research with Third Nerve today.